Monday, December 19, 2016

CORRECTED-UPDATE 1-Ionis Pharma's rare metabolic disorder drug succeeds key study

Dec 19 (Reuters) - Ionis Pharmaceuticals Inc said

on Monday its rare metabolic disorder drug for severe

hypertriglyceridemia, characterized by elevated levels of a type

of fat in the blood, met the main goal in a late-stage study.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)